NCT05640882

Brief Summary

Participants arriving to the ED following a potentially traumatic event such as a motor vehicle accident will be recruited into the study. Inclusion criteria: aged 18-65, Hebrew as a first language, no current psychiatric disorder. Exclusion criteria: loss of consciousness, unable to understand study procedure. Participants will answer self report questionnaires in the ED. They will be invited for a follow up interview 2 weeks and six months post trauma. Between 2 weeks and 6 months they will be folllowed up via online questionnaires. At the interviews, they will encounter 20 different olfactory stimuli, answer self-report questionnaires, and a clinical interview assessing Axis 1 disorders and PTSD will be completed. At six month, participants with PTSD will be offered therapy in the embedded RCT. Patients will receive VRET (Virtual reality exposure therapy) with or without olfaction.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2023

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 17, 2022

Completed
20 days until next milestone

First Posted

Study publicly available on registry

December 7, 2022

Completed
25 days until next milestone

Study Start

First participant enrolled

January 1, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

December 7, 2022

Status Verified

November 1, 2022

Enrollment Period

2 years

First QC Date

November 17, 2022

Last Update Submit

November 28, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • PTSD Status

    PTSD diagnosis as measured by the CAPS

    3 months after end of treatment

  • PTSD Levels

    PTSD Symptoms Levels as measured by the CAPS continuous score

    3 months after end of treatment

Other Outcomes (1)

  • PTSD Symptoms Levels Before Treatment

    6 months post traumatic event

Study Arms (2)

VRET

EXPERIMENTAL

VRET - 10 week protocol using VR

Other: VRET

VRET Olfaction

ACTIVE COMPARATOR

VRET olfaction - 10 week protocol using VR with olfaction

Other: VRET OLFACTION

Interventions

VRETOTHER

10 week prolonged exposure protocol, using Virtual Reality for imaginal exposure

VRET

10 week prolonged exposure protocol, using Virtual Reality for imaginal exposure with the addition of olfaction

VRET Olfaction

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • hebrew native speaker
  • understand study requirements

You may not qualify if:

  • current psychiatric disorder
  • suicidality
  • vertigo
  • epilepsy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Central Study Contacts

Sara Freedman, Prof.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
prof.

Study Record Dates

First Submitted

November 17, 2022

First Posted

December 7, 2022

Study Start

January 1, 2023

Primary Completion

January 1, 2025

Study Completion

January 1, 2026

Last Updated

December 7, 2022

Record last verified: 2022-11